AssayComplete™ Cell Plating 0 Reagent from DiscoverX

DiscoveRx Corporation 42501 Albrae St.

Fremont, California 94538

United States

Phone: (510) 979-1415

Email: CustomerServiceDRX@eurofins.com

(1) Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonistNeuropharmacologyApril 1, 2017Ardestani PM, Evans AK, Yi B, Nguyen T, Coutellier L, Shamloo M.CHO-K1-B2 PathHunter cell lines were plated in a total volume of 20 μL cell plating reagent (DiscoveRx, 93-0563R0A) at a density of 2,500 cells/well into 384 well microplates and incubated overnight at 37°C in 5 % CO2.

(2) Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disordersPloS oneJanuary 1, 2017Yi B, Jahangir A, Evans AK, Briggs D, Ravina K, Ernest J, Farimani AB, Sun W, Rajadas J, Green M, et al.CHO-K1-ADRB1 PathHunter cell lines were plated in a total volume of 20 μL cell plating reagent (DiscoveRx, 93-0563R0A) at a density of 2,500 cells/well into 384 well microplates and incubated overnight at 37°C in 5% CO2.

Citations (2)